Dear Colleague,

GTC is proud to present the 6th Biomarker Development Conference as part of the Biomarker Summit 2012.

Returning for its sixth installment, the Conference will once again be the gathering center for professionals in the biomarker development industry.

Biomarker Development remains one of the most important aspects in the pharmaceutical industry and will continue to push advancements well into the future. As the nearly $13 billion biomarker market continues to advance, its complexity grows as well. It is essential that the industry is in tune with the latest developments and breakthroughs, especially in the current economic and regulatory environment. Only those armed with the highest caliber intelligence will be able to compete and continue to contribute to this vital industry.

The 6th Biomarker Development Conference offers attendees insight into the latest developments from the leading players will offering a unique networking opportunity.

Beyond simply attending a conference, attendees will be part of the larger Biomarker Summit 2012 that also includes:

Biomarker and Diagnostics Conference
4th Oncology Biomarker Conference
Biomarker Partnering and Deal-Making Conference

Limitless networking opportunities will be provided for attendees across all four Summit tracks. We look forward to welcoming you to the Biomarker Summit 2012!

Attend ALL 2012 GTCbio Conferences for only $3995 industry rate or $1990 acad/govt rate. Click here to sign up!